TP53 and prostate carcinoma: Oh et al. [9] showed that knockdown of UBB in neuroblastoma, hepatocarcinoma, breast and prostate cancer cell lines led to an increase in p53 and cleaved PARP1 levels, induction of G2/M block, increase in the number of apoptotic cells and decrease in cancer cell proliferation rates.